Section of Infectious Diseases and Tropical Medicine

Patient Care

​The specialist care of patients with suspected or proven infectious diseases takes place within the framework

  • patient care at the Department of Internal Medicine
  • the hospitalwide Infectious Diseases Consultation service and
  • the Outpatient Clinic for Infectious Diseases and Tropical Medicine.

The hospitalwide Infectious Diseases Consultation service provides specialized patient care to patients on various wards or outpatient clinics across the hospital and also provides tele-consultation service by phone for facilities outside the University Hospital. "Antimicrobial Stewardship" measures are implemented in cooperation with the local pharmacy and colleagues of the University Hospital.

In the Infectious Diseases Outpatient Clinic patients are followed up after inpatient treatment, or examined and treated after referral by colleagues (e.g. fever after stay in tropical areas), or examined and treated in infectious emergencies in cooperation with the Emergency facility  (EBA). Day-hospital service (e.g. outpatient parenteral antimicrobial therapy OPAT) is provided in collaboration with the Day-hospital facility located in the Department of Internal Medicine.
Our patient care mandate currently does not include medical consultations PRIOR to a trip. In case of question regarding vaccinations or other measures before traveling abroad, please contact the Institute of Hygiene, Microbiology and Environmental Medicine of the Medical University of Graz or another vaccination center.

Our Microbiology Laboratory, located in the Department of Internal Medicine, is integrated into Austrian (AURES) and European (EARS-Net) resistance data networks. Provision of local epidemiological and resistance data enable high quality antimicrobial therapies. Short distances for transport of microbiological specimens and immediate reaction to microbiology reports enhance quality of treatment and lead to better outcomes, as shown e.g. in patient suffering from Staphylococcus aureus bacteremia with improved survival rates and fewer relapses.

Letzte Aktualisierung: 21.10.2017